Memory in retroviral quasispecies: Experimental evidence and theoretical model for human immunodeficiency virus

Journal of Molecular Biology

Volumn 331, Issue 1, 2003, Pages 213-229

  Briones, Carlos ^a   Domingo, Esteban ^a,b   Molina París, Carmen ^c,d  

^a CENTRO DE ASTROBIOLOGÍA CSIC INTA   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Human immunodeficiency virus; Memory; Quasispecies; Retroviruses; Viral reservoirs

Indexed keywords

ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MATHEMATICAL MODEL; MEMORY; MICROSCOPIC ANATOMY; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROVIRUS; THEORY; VIRUS GENOME; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0038499539     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00661-2     Document Type: Article

References (79)

1. Eigen M., Biebricher C.K. Sequence space and quasispecies distribution. Domingo E., Ahlquist P., Holland J.J. RNA Genetics. vol. 3:1988;CRC Press, Boca Raton, FL.
2. Eigen M. On the nature of virus quasispecies. Trends Microbiol. 4:1996;216-218.
3. Domingo E., Biebricher C., Holland J.J., Eigen M. Quasispecies and RNA Virus Evolution: Principles and Consequences. 2001;Landes, Austin, TX.
4. Eigen M. Self-organization of matter and evolution of biological macromolecules. Naturwissenschaften. 58:1971;465-523.
5. Eigen M. Error catastrophe and antiviral strategy. Proc. Natl Acad. Sci. USA. 99:2002;13374-13376.
6. Ruíz-Jarabo C.M., Arias A., Baranowski E., Escarmís C., Domingo E. Memory in viral quasispecies. J. Virol. 74:2000;3543-3547.
7. Arias A., Lázaro E., Escarmís C., Domingo E. Molecular intermediates of fitness gain of an RNA virus: characterization of a mutant spectrum by biological and molecular cloning. J. Gen. Virol. 82:2001;1049-1060.
8. Ruíz-Jarabo C.M., Arias A., Molina-París C., Briones C., Baranowski E., Escarmís C., Domingo E. Duration and fitness dependence of quasispecies memory. J. Mol. Biol. 315:2002;285-296.
9. Domingo E. Viruses at the edge of adaptation. Virology. 270:2000;251-253.
10. Meyerhans A., Cheynier R., Albert J., Seth M., Kwok S., Sninsky J., et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell. 58:1989;901-910.
11. Crandall K.A. The Evolution of HIV. 1999;The Johns Hopkins University Press, Baltimore, MD.
12. Goff S.P. Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways. J. Gene Med. 3:2001;517-528.
13. Friedberg E.C., Walker G.C., Siede W. DNA Repair and Mutagenesis. 1995;American Society of Microbiology, Washington.
14. Pantaleo G., Graziosi C., Butini L. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl Acad. Sci. USA. 88:1991;9838-9842.
15. Finzi D., Hermankova M., Pierson T. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 278:1997;1295-1300.
16. Blankson J.N., Persaud D., Siciliano R.F. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53:2002;557-593.
17. Devereux H.L., Burke A., Lee C.A., Johnson M.A. In vivo HIV-1 compartmentalisation: drug resistance-associated mutation distribution. J. Med. Virol. 66:2002;8-12.
18. Ruff C.T., Ray S.C., Kwon P., Zinn R., Pendleton A., Hutton N., et al. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. J. Virol. 76:2002;9481-9492.
19. Karlsson A.C., Gaines H., Sällberg M., Lindbäck S., Sönnerborg A. Reappearance of founder virus sequence in human immunodeficiency virus type 1-infected patients. J. Virol. 73:1999;6191-6196.
20. Miller V. Structured treatment interruptions in antiretroviral management of HIV-1. Curr. Opin. Infect. Dis. 14:2001;29-37.
21. Kijak G.H., Simon V., Balfe P., Vanderhoeven J., Pampuro S.E., Zala C., et al. Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure. J. Virol. 76:2002;7000-7009.
22. Deeks S.G., Grant R.M., Wrin T., Paxinos E.E., Liegler T., Hoh R., et al. Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response. AIDS. 17:2003;361-370.
23. Perelson A., Neumann A., Markowitz M. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 271:1996;1582-1586.
24. Perelson A., Essunger P., Cao Y. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature. 387:1997;188-190.
25. Ho D.D. Dynamics of HIV-1 replication in vivo. J. Clin. Invest. 11:1997;2565-2567.
26. Markowitz M.H. HIV pathogenesis and viral dynamics. Antiviral Ther. 2:1997;7-17.
27. Cavert W., Notermans D., Staskus K. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science. 276:1997;960-964.
28. Wodarz D., Nowak M.A. Dynamics of HIV Pathogenesis and Treatment. Domingo E., Webster R.G., Holland J.J. Origin and Evolution of Viruses. 1999;Academic Press, San Diego, CA.
29. Schinazi R., Larder B., Mellors J. Mutations in retroviral genes associated with drug resistance: 1999-2000 update. Int. Antiviral News. 7:1999;46-49.
30. Yeni P.G., Hammer S.M., Carpenter C.C., Cooper D.A., Fischl M.A., Gatell J.M., et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society - USA Panel. J. Am. Med. Assoc. 288:2002;222-235.
31. Batschelet E., Domingo E., Weissmann C. The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate. Gene. 1:1976;27-32.
32. Rowe G. Theoretical Models in Biology: The Origin of Life, the Immune System, and the Brain. 1994;Clarendon, Oxford, UK.
33. Bonhoeffer S., May R.M., Shaw G.M., Nowak M.A. Virus dynamics and drug therapy. Proc. Natl Acad. Sci. USA. 94:1997;6971-6976.
34. Wein L.M., D'Amato R.M., Perelson A.S. Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads. J. Theor. Biol. 192:1998;81-98.
35. Ribeiro R.M., Bonhoeffer S. The frequency of resistant mutant virus before antiviral therapy. AIDS. 12:1998;461-465.
36. Mittler J.E., Sulzer B., Neumann A.U., Perelson A.S. Influence of delayed viral production on viral dynamics in HIV-1 infected patients. Math. Biosci. 152:1998;143-163.
37. Ribeiro R.M., Bonhoeffer S. A stochastic model for primary HIV infection: optimal timing of therapy. AIDS. 13:1999;351-357.
38. Rouzine I.M., Coffin J.M. Linkage disequilibrium test implies a large effective population number for HIV in vivo. Proc. Natl Acad. Sci. USA. 96:1999;10758-10763.
39. Rouzine I.M., Coffin J.M. Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus. J. Virol. 73:1999;8167-8178.
40. Nelson P.W., Murray J.D., Perelson A.S. A model of HIV-1 pathogenesis that includes an intracellular delay. Math. Biosci. 163:2000;201-215.
41. Ribeiro R.M., Bonhoeffer S. Production of resistant HIV mutants during antiretroviral therapy. Proc. Natl Acad. Sci USA. 97:2000;7681-7686.
42. Stafford M.A., Corey L., Cao Y., Daar E.S., Ho D.D., Perelson A.S. Modeling plasma virus concentration during primary HIV infection. J. Theor. Biol. 203:2000;285-301.
43. Rouzine I.M., Rodrigo A., Coffin J.M. Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology. Microbiol. Mol. Biol. Rev. 65:2001;151-185.
44. Eigen M., Schuster P. The hypercycle. A principle of natural self-organization. Part A: emergence of the hypercycle. Naturwissenschaften. 64:1977;541-565.
45. Biebricher C.K., Eigen M., Gardiner W.C. Jr. Kinetics of RNA replication: competition and selection among self-replicating RNA species. Biochemistry. 24:1985;6550-6560.
46. Biebricher C.K. Mutation, competition and selection as measured with small RNA molecules. Domingo E., Webster R.G., Holland J.J. Origin and Evolution of Viruses. 1999;Academic Press, San Diego, CA.
47. Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3:1997;205-211.
48. Wyatt C.A., Andrus L., Brotman B., Huang F., Lee D.H., Prince A.M. Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection. J. Virol. 72:1998;1725-1730.
49. Lau G.K., Tsiang M., Hou J., Yuen S., Carman W.F., et al. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study. Hepatology. 32:2000;394-399.
50. Kuiken C.L., Foley B., Hahn B., Korber B., McCutchan F., Marx P.A., et al. Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. 2000;Los Alamos National Laboratory, Los Alamos, NM.
51. Briones C., Mas A., Gómez-Mariano G., Altisent C., Menéndez-Arias L., Soriano V., Domingo E. Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to a prolonged therapy. Virus Res. 66:2000;13-26.
52. Leitner T., Kumar S., Albert J. Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history. J. Virol. 71:1997;4761-4770.
53. Li W.-H., Tanimura M., Sharp P.M. Rates and dates of divergence between AIDS virus nucleotide sequences. Mol. Biol. Evol. 5:1988;313-330.
54. Ou C.Y., Ciesielski C.A., Myers G., Bandea C.I., Luo C.-C., Korber B.T.M., et al. Molecular epidemiology of HIV transmission in a dental practice. Science. 256:1992;1165-1171.
55. Myers G., MacInnes K., Korber B. The emergence of simian/human immunodeficiency viruses. AIDS Res. Hum. Retroviruses. 8:1992;373-386.
56. Domingo E., Webster R.G., Holland J.J. Origin and Evolution of Viruses. 1999;Academic Press, San Diego, CA.
57. De Antoni A., Foli A., Lisziewicz J., Lori F. Mutations in the pol gene of human immunodeficiency virus type 1 in infected patients receiving didanosine and hydroxyurea combination therapy. J. Infect. Dis. 176:1997;899-903.
58. Winters M.A., Coolley K.L., Girard Y.A., Levee D.L., Hamdan H., Shafer R.W., et al. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. J. Clin. Invest. 102:1998;1769-1775.
59. Mas A., Parera M., Briones C., Soriano V., Martínez M.A., Domingo E., Menéndez-Arias L. Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance. EMBO J. 19:2000;5752-5761.
60. Lukashof V.V., Huismans R., Jebbink M.F., Danner S.A., de Boer R.J., Goudsmit J. Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs. AIDS Res. Hum. Retroviruses. 17:2001;807-818.
61. Domingo E., Ruíz-Jarabo C.M., Arias A., Molina-París C., Briones C., Baranowski E., Escarmís C. Detection and biological implications of genetic memory in viral quasispecies. Matsumory A. Proceedings of the International Congress on Cardiomyopathies and heart failure. 2003;Kluwer Academic Publishers, London, UK. in the press.
62. Gerry N.P., Witowski N.E., Day J., Hammer R.P., Barany G., Barany F. Universal DNA microarray method for multiplex detection of low abundance point mutations. J. Mol. Biol. 292:1999;251-262.
63. Fei Z., Smith L.M. Analysis of single nucleotide polymorphisms by primer extension and matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 14:2000;950-959.
64. Amexis G., Oeth P., Abel K., Ivshina A., Pelloquin F., Cantor C.R., et al. Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. Proc. Natl Acad. Sci. USA. 98:2001;12097-12102.
65. Kern D., Collins M., Fultz T., Detmer J., Hamren S., Peterkin J.J., et al. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:1996;3196-3202.
66. Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheimvan Dillen P.M., van der Noordaa J. Rapid and simple methods for purification of nucleic acids. J. Clin. Microbiol. 28:1990;495-503.
67. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22:1994;4673-4680.
68. Felsenstein, J. (1991). PHYLIP (Phylogeny Inference Package) version 3.5. University of Washington, Seattle.
69. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:1987;406-425.
70. Swofford D.L., Olsen G.J. Phylogeny reconstruction. Hillis D.M., Moritz C. Molecular Systematics. 1990;Sinauer Associates, Sunderland, UK.
71. Sober E. Reconstructing the Past: Parsimony, Evolution and Inference. 1988;MIT Press, Cambridge, MA.
72. Stewart C.B. The powers and pitfalls of parsimony. Nature. 361:1993;603-607.
73. Louwagie J., McCutchan F.E., Peeters M., Brennan T.P., Sanders-Buell E., Eddy G.A., et al. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS. 7:1993;769-780.
74. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 39:1985;738-791.
75. Strimmer K., von Haeseler A. Likelihood mapping: a simple method to visualize phylogenetic content of a sequence alignment. Proc. Natl Acad. Sci. USA. 94:1997;6815-6819.
76. Tamura K., Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol. Biol. Evol. 10:1993;512-526.
77. Salemi M., Lewis M., Egan J.F., Hall W.W., Desmyter J., Vandamme A.M. Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc. Natl Acad. Sci. USA. 96:1999;13253-13258.
78. Harbison S.P., Steele G.L. C, A Reference Manual. 1995;Prentice-Hall, Englewood Cliffs, NJ.
79. Press W.H. Numerical Recipes in C: The Art of Scientific Computing. 1988;Cambridge University Press, Cambridge, UK.